Clinical Trial Update: Determination of Gentamicin Dosing in Neonatal Patients [Phase 4]

View source ↗

Summary

The Phase 4 study evaluated optimal dosing of gentamicin in neonates with infections. Completed results may inform neonatal dosing guidelines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Infection | Phase 4 | Status: COMPLETED